BSE filing, NSE: BAFNAPH. Summary written from the filing by ALFA Finder's alert engine.
Bafna Pharmaceuticals Ltd: key numbers
- Share price
- ₹456.50
- Market cap
- ₹1,080 Cr
- Revenue (annual)
- ₹150.6 Cr
- Net profit (annual)
- ₹11.10 Cr
- P/E (TTM)
- 138.7×Sector 42.0×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 9.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bafna Pharmaceuticals Ltd
All →Bafna Pharmaceuticals Other Announcement
Bafna Pharmaceuticals Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Bafna Pharmaceuticals Annual General Meeting
Bafna Pharmaceuticals' 31st AGM held on September 11, 2026 approved adoption of audited financials, a director re-appointment, and cost auditor ratification. No specific monetary transaction was transacted.
Bafna Pharmaceuticals Annual Report
Bafna Pharmaceuticals Limited has submitted its Annual Report for the financial year 2025-2026 and announced the date for its 31st Annual General Meeting.
Bafna Pharmaceuticals Annual General Meeting
Bafna Pharmaceuticals Limited will hold its 31st Annual General Meeting on September 11, 2026. The book closure is scheduled from September 05 to September 11, 2026.
Bafna Pharmaceuticals Q1 FY27 Results: Net Profit ₹0.1 Cr, Down 97.1% YoY
Bafna Pharmaceuticals Ltd reported revenue from operations of ₹26.6 Cr (-23.1% YoY) and net profit of ₹0.1 Cr (-97.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.1 Cr · -97.1% YoY
Bafna Pharmaceuticals Board Meeting Date
Bafna Pharmaceuticals has scheduled a board meeting for August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other board meeting date announcements
All →Asgard Alcobev Board Meeting Date
Asgard Alcobev intimated BSE of a board meeting on November 13, 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window is closed from October 1 to November 16, 2026.
Disa India Board Meeting Date
DISA India intimated BSE of a board meeting on November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Results are the key investor catalyst.
Smart Finsec Board Meeting Date
Smart Finsec intimated BSE of a board meeting on November 13, 2026 to consider unaudited standalone results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results.
Shiva Suitings Board Meeting Date
Shiva Suitings scheduled a board meeting on 13 November 2026 to approve unaudited results for the quarter ended September 2026. Prior intimation was issued 6 November 2026.
TVS Supply Chain Solutions Board Meeting Date
TVS Supply Chain Solutions intimated BSE of a board meeting on November 13, 2026 to consider unaudited standalone and consolidated results for the quarter and half-year ended September 30, 2026. The trading window stays closed from October 1 until 48 hours after the results are made public.
Shellz India Board Meeting Date
Shellz India Ltd scheduled a board meeting on 14 November 2026 to approve unaudited half-year financial results ended September 2026. Prior intimation issued 6 November 2026.